Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,557 across all filing types
Latest filing 2008-09-11 AGM Information
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting/Proxy Form 10 pages ?Kb
AGM Information Classification · 100% confidence The document is an invitation and notice for the 18th Annual General Meeting (AGM) of CSL Limited, including details about the meeting logistics, proxy voting instructions, agenda items such as election of directors, adoption of the remuneration report, and information on significant foreign shareholders. It contains no financial statements or detailed financial data but rather serves as a formal notice and explanatory notes for shareholders to prepare for the AGM. The presence of proxy forms, meeting date, and agenda items confirms this is an AGM notice document. Therefore, the document fits the category of AGM Information (AGM-R). The document length and content confirm it is not a brief announcement or a report publication announcement but a full AGM notice.
2008-09-11 English
Annual Report to shareholders 126 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2007-2008' and contains detailed financial results, business reviews, dividend information, and operational highlights for the fiscal year ended 30 June 2008. It includes comprehensive financial data such as revenue, profit, dividends, and segment sales, as well as management commentary and strategic business information. The length of the document (15,000 characters) and the depth of financial and operational detail confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2008
2008-09-11 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class, number, terms, issue price, purpose, and quotation application for additional securities. It references ASX rules and compliance with the Corporations Act, indicating it is a formal announcement related to capital raising or share issuance. The document does not contain financial statements or management discussion but focuses on the announcement of new share issues and their quotation on the exchange. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes.
2008-09-10 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose, and quotation application to the ASX. It references specific ASX rules and includes sections on quotation agreements and warranties. The content is consistent with a formal announcement of new share issuance and application for quotation rather than a full financial report or earnings release. The document length is over 10,000 characters, indicating it is a substantive announcement rather than a brief notice. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital structure changes.
2008-09-04 English
Initial Directors Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, indicating it is a report of personal share transactions or interests by a company director. The document length is short (2166 characters) and contains no financial statements or company performance data. This matches the definition of Director's Dealing filings, which report personal share transactions or interests of directors and executives.
2008-09-02 English
Director Appointment/Resignation 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new director to the company's board. It contains no financial data, no report or presentation, and no regulatory filings related to financial performance or governance rules. The content focuses solely on management changes, specifically the appointment of Mr. David Anstice as a director. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and does not indicate any other report or announcement type.
2008-09-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.